These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 4683093

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride.
    Reveno WS, Bauer RB, Rosenbaum H.
    Geriatrics; 1971 Aug; 26(8):61-70. PubMed ID: 5096462
    [No Abstract] [Full Text] [Related]

  • 3. [Results of treatment of Parkinsonism with L-dopa].
    De Divitiis E, D'Andrea F, Signorelli CD.
    Sist Nerv; 1970 Aug; 22(2):99-108. PubMed ID: 5504563
    [No Abstract] [Full Text] [Related]

  • 4. Failures of L-dopa.
    Paulson GW.
    Ohio State Med J; 1973 Dec; 69(12):896-8. PubMed ID: 4769406
    [No Abstract] [Full Text] [Related]

  • 5. [L-dopa treatment of persons with parkinsonism in a hospital for geriatric rehabilitation].
    Antonini F, Baroni A, Roveyaz L.
    Sist Nerv; 1970 Dec; 22(2):74-81. PubMed ID: 5504560
    [No Abstract] [Full Text] [Related]

  • 6. Levodopa and amantadine in the treatment of Parkinsonism.
    Critchley E.
    Practitioner; 1972 Apr; 208(246):499-504. PubMed ID: 5031037
    [No Abstract] [Full Text] [Related]

  • 7. [Case reports of some mental disorders in parkinsonian patients treated with L-dopa].
    Almici GM, Sbarbaro V.
    Minerva Med; 1974 Feb 03; 65(8):398-401. PubMed ID: 4820722
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of Parkinsonic syndrome with levo-Dopa. Case reports].
    Rosati G, Agnetti V, Mura F, Granieri E.
    Minerva Med; 1974 May 02; 65(33):1811-23. PubMed ID: 4602058
    [No Abstract] [Full Text] [Related]

  • 9. [10 years of L-DOPA therapy of Parkinson's syndrome].
    Birkmayer W.
    Wien Klin Wochenschr; 1971 Apr 02; 83(13):221-7. PubMed ID: 4254333
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of parkinsonism with levo-dopa: results in 302 cases.
    Newkirk TA, Magee KR.
    Mich Med; 1971 Sep 02; 70(22):805-11. PubMed ID: 5141211
    [No Abstract] [Full Text] [Related]

  • 11. [Problems and therapy of L-DOPA-induced dyskinesias].
    Völler GW, Deze J, Gundlach U, Muschard F.
    Nervenarzt; 1972 Nov 02; 43(11):584-6. PubMed ID: 4564994
    [No Abstract] [Full Text] [Related]

  • 12. L-dopa and amantadine hydrochloride in Parkinson's disease.
    Parkes JD, Zilkha KJ, Knill-Jones RP, Clements PJ, Baxter R.
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr 02; 4(3):356-60. PubMed ID: 4931417
    [No Abstract] [Full Text] [Related]

  • 13. Parkinson's disease treated with L-dopa. Three-year follow-up report.
    Mones RJ.
    N Y State J Med; 1972 Nov 15; 72(22):2749-50. PubMed ID: 4510706
    [No Abstract] [Full Text] [Related]

  • 14. Differentiation of tardive dyskinesias and drug-induced Parkinsonism.
    N Engl J Med; 1971 Jun 17; 284(24):1382-4. PubMed ID: 5576464
    [No Abstract] [Full Text] [Related]

  • 15. Side effects of L-dopa treatment.
    Greenburg J.
    Pa Med; 1971 Apr 17; 74(4):55-6. PubMed ID: 5147645
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. L-dopa and amantadine for Parkinsonism.
    Drug Ther Bull; 1970 Aug 14; 8(17):65-7. PubMed ID: 5480244
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.